MTOR and tuberculosis: Among the proposed molecules “to repurpose” against TB is Everolimus, a molecule that exerts immunosuppressant activity by inhibiting the mTOR pathway and blocking growth-factor driven T-cell proliferation [11] that has been described as exerting both anti-mycobacterial and immunomodulatory activities [12,13].